Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Hafron

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
The Urologic Clinics of North America|April 2, 2021
Understanding the Millennial PhysicianJake Quarles, Jason Hafron
Cancer Control : Journal of the Moffitt Cancer Center|July 7, 2007
Cryosurgical ablation of renal cell carcinomaJason Hafron, Jihad H Kaouk
Expert Review of Medical Devices|March 12, 2008
Technical advances in urological laparoscopic surgeryJason Hafron, Jihad H Kaouk
The Journal of Urology|December 6, 2022
Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate CancerCelestia S Higano, Jason Hafron
Nature Clinical Practice. Urology|May 8, 2007
Ablative techniques for the management of kidney cancerJason Hafron, Jihad H Kaouk
The Journal of Urology|May 9, 2024
Editorial CommentJason Hafron, Bernadette M M Zwaans
International Journal of Molecular Sciences|May 11, 2024
Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical AdministrationPradeep Tyagi, Jason Hafron, Jonathan Kaufman, et al.
The Journal of Urology|January 5, 2024
Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone AntagonistMarc B Garnick, Jason Hafron, E David Crawford
Urology Practice|August 30, 2023
Adherence to Hormonal Therapies in Prostate CancerJason Hafron, Parjosh Sangha, Tiffany Kung, et al.
BJU International|February 1, 2005
Surgery for localized prostate cancer after renal transplantationJason Hafron, James D Fogarty, Ari Wiesen, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
The Urologic Clinics of North America|April 2, 2021
Understanding the Millennial PhysicianJake Quarles, Jason Hafron
Cancer Control : Journal of the Moffitt Cancer Center|July 7, 2007
Cryosurgical ablation of renal cell carcinomaJason Hafron, Jihad H Kaouk
Expert Review of Medical Devices|March 12, 2008
Technical advances in urological laparoscopic surgeryJason Hafron, Jihad H Kaouk
The Journal of Urology|December 6, 2022
Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate CancerCelestia S Higano, Jason Hafron
Nature Clinical Practice. Urology|May 8, 2007
Ablative techniques for the management of kidney cancerJason Hafron, Jihad H Kaouk
The Journal of Urology|May 9, 2024
Editorial CommentJason Hafron, Bernadette M M Zwaans
International Journal of Molecular Sciences|May 11, 2024
Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical AdministrationPradeep Tyagi, Jason Hafron, Jonathan Kaufman, et al.
The Journal of Urology|January 5, 2024
Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone AntagonistMarc B Garnick, Jason Hafron, E David Crawford
Urology Practice|August 30, 2023
Adherence to Hormonal Therapies in Prostate CancerJason Hafron, Parjosh Sangha, Tiffany Kung, et al.
BJU International|February 1, 2005
Surgery for localized prostate cancer after renal transplantationJason Hafron, James D Fogarty, Ari Wiesen, et al.
Pageof 8